{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T16:16:18Z","timestamp":1790612178043,"version":"4.1.0"},"reference-count":42,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100002858","name":"China Postdoctoral Science Foundation","doi-asserted-by":"publisher","award":["2018T110985"],"award-info":[{"award-number":["2018T110985"]}],"id":[{"id":"10.13039\/501100002858","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100012542","name":"Sichuan Province Science and Technology Support Program","doi-asserted-by":"publisher","award":["2018RZ0136"],"award-info":[{"award-number":["2018RZ0136"]}],"id":[{"id":"10.13039\/100012542","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81974499"],"award-info":[{"award-number":["81974499"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Pharmaceutics and Biopharmaceutics"],"published-print":{"date-parts":[[2021,8]]},"DOI":"10.1016\/j.ejpb.2021.05.014","type":"journal-article","created":{"date-parts":[[2021,5,19]],"date-time":"2021-05-19T00:52:47Z","timestamp":1621385567000},"page":"164-173","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":45,"special_numbering":"C","title":["Phenylboronic acid modified nanoparticles simultaneously target pancreatic cancer and its metastasis and alleviate immunosuppression"],"prefix":"10.1016","volume":"165","author":[{"given":"Zhengze","family":"Lu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yang","family":"Long","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yashi","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuhui","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chunyu","family":"Xia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Man","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhirong","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qin","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejpb.2021.05.014_b0005","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1038\/ncb3340","article-title":"Macrophage-secreted granulin supports pancreatic cancer metastasis by inducing liver fibrosis","volume":"18","author":"Nielsen","year":"2016","journal-title":"Nat. Cell Biol."},{"key":"10.1016\/j.ejpb.2021.05.014_b0010","doi-asserted-by":"crossref","first-page":"2913","DOI":"10.1158\/0008-5472.CAN-14-0155","article-title":"Projecting cancer incidence and deaths to 2030: The unexpected burden of thyroid, liver, and pancreas cancers in the United States","volume":"74","author":"Rahib","year":"2014","journal-title":"Cancer Res."},{"key":"10.1016\/j.ejpb.2021.05.014_b0015","doi-asserted-by":"crossref","first-page":"1048","DOI":"10.15252\/emmm.201404837","article-title":"Transcriptional co-factor transducin beta-like (TBL) 1 acts as a checkpoint in pancreatic cancer malignancy","volume":"7","author":"Stoy","year":"2015","journal-title":"EMBO Mol. Med."},{"key":"10.1016\/j.ejpb.2021.05.014_b0020","doi-asserted-by":"crossref","first-page":"1500","DOI":"10.1093\/annonc\/mdq545","article-title":"Pancreatic cancer treatment and research: An international expert panel discussion","volume":"22","author":"Tempero","year":"2011","journal-title":"Ann. Oncol."},{"key":"10.1016\/j.ejpb.2021.05.014_b0025","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1038\/s41467-020-14425-7","article-title":"Dual-mechanism based CTLs infiltration enhancement initiated by nano-sapper potentiates immunotherapy against immune-excluded tumors","volume":"11","author":"Huang","year":"2020","journal-title":"Nat. Commun."},{"key":"10.1016\/j.ejpb.2021.05.014_b0030","doi-asserted-by":"crossref","first-page":"230","DOI":"10.5306\/wjco.v8.i3.230","article-title":"Immunotherapy in pancreatic cancer: Unleash its potential through novel combinations","volume":"8","author":"Guo","year":"2017","journal-title":"World J. Clin. Oncol."},{"key":"10.1016\/j.ejpb.2021.05.014_b0035","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1111\/j.1365-2567.2009.03105.x","article-title":"Increase in frequency of myeloid-derived suppressor cells in mice with spontaneous pancreatic carcinoma","volume":"128","author":"Zhao","year":"2009","journal-title":"Immunology"},{"key":"10.1016\/j.ejpb.2021.05.014_b0040","doi-asserted-by":"crossref","first-page":"1812","DOI":"10.1158\/1078-0432.CCR-09-3272","article-title":"Anti-inflammatory triterpenoid blocks immune suppressive function of MDSCs and improves immune response in cancer","volume":"16","author":"Nagaraj","year":"2010","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.ejpb.2021.05.014_b0045","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.cytogfr.2018.01.007","article-title":"The role of inflammatory cytokines and tumor associated macrophages (TAMs) in microenvironment of pancreatic cancer","volume":"39","author":"Valilou","year":"2018","journal-title":"Cytokine Growth Factor Rev."},{"key":"10.1016\/j.ejpb.2021.05.014_b0050","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1097\/CJI.0b013e318189f13c","article-title":"Tumor-derived TGF-beta mediates conversion of CD4+Foxp3+ regulatory T cells in a murine model of pancreas cancer","volume":"32","author":"Moo-Young","year":"2009","journal-title":"J. Immunother."},{"key":"10.1016\/j.ejpb.2021.05.014_b0055","doi-asserted-by":"crossref","first-page":"4063","DOI":"10.4049\/jimmunol.0902609","article-title":"Induction of Th17 cells in the tumor microenvironment improves survival in a murine model of pancreatic cancer","volume":"185","author":"Gnerlich","year":"2010","journal-title":"J. Immunol."},{"key":"10.1016\/j.ejpb.2021.05.014_b0060","doi-asserted-by":"crossref","first-page":"1373","DOI":"10.1007\/s00262-011-1178-0","article-title":"Pancreatic adenocarcinoma induces bone marrow mobilization of myeloid-derived suppressor cells which promote primary tumor growth","volume":"61","author":"Porembka","year":"2012","journal-title":"Cancer Immunol. Immunother."},{"key":"10.1016\/j.ejpb.2021.05.014_b0065","doi-asserted-by":"crossref","first-page":"734","DOI":"10.2174\/156800911796191024","article-title":"Myeloid-derived suppressor cells: general characteristics and relevance to clinical management of pancreatic cancer","volume":"11","author":"Goedegebuure","year":"2011","journal-title":"Curr. Cancer Drug Targets"},{"key":"10.1016\/j.ejpb.2021.05.014_b0070","doi-asserted-by":"crossref","first-page":"1419","DOI":"10.1007\/s00262-011-1028-0","article-title":"Elevated myeloid-derived suppressor cells in pancreatic, esophageal and gastric cancer are an independent prognostic factor and are associated with significant elevation of the Th2 cytokine interleukin-13","volume":"60","author":"Gabitass","year":"2011","journal-title":"Cancer Immunol. Immunother."},{"key":"10.1016\/j.ejpb.2021.05.014_b0075","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1021\/acs.nanolett.9b03753","article-title":"Pseudoneutrophil cytokine sponges disrupt myeloid expansion and tumor trafficking to improve cancer immunotherapy","volume":"20","author":"Li","year":"2020","journal-title":"Nano Lett."},{"key":"10.1016\/j.ejpb.2021.05.014_b0080","doi-asserted-by":"crossref","first-page":"1114","DOI":"10.1038\/nature09515","article-title":"Distant metastasis occurs late during the genetic evolution of pancreatic cancer","volume":"467","author":"Yachida","year":"2010","journal-title":"Nature"},{"key":"10.1016\/j.ejpb.2021.05.014_b0085","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1038\/ncb3169","article-title":"Pancreatic cancer exosomes initiate pre-metastatic niche formation in the liver","volume":"17","author":"Costa-Silva","year":"2015","journal-title":"Nat. Cell Biol."},{"key":"10.1016\/j.ejpb.2021.05.014_b0090","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.1038\/nature09460","article-title":"The patterns and dynamics of genomic instability in metastatic pancreatic cancer","volume":"467","author":"Campbell","year":"2010","journal-title":"Nature"},{"key":"10.1016\/j.ejpb.2021.05.014_b0095","doi-asserted-by":"crossref","first-page":"172","DOI":"10.3389\/fimmu.2019.00172","article-title":"MDSCs: Key criminals of tumor pre-metastatic niche formation","volume":"10","author":"Wang","year":"2019","journal-title":"Front. Immunol."},{"key":"10.1016\/j.ejpb.2021.05.014_b0100","doi-asserted-by":"crossref","first-page":"3024","DOI":"10.1002\/jcp.26075","article-title":"Myeloid-derived suppressor cells: Important contributors to tumor progression and metastasis","volume":"233","author":"Safarzadeh","year":"2018","journal-title":"J. Cell. Physiol."},{"key":"10.1016\/j.ejpb.2021.05.014_b0105","doi-asserted-by":"crossref","first-page":"3289","DOI":"10.1182\/blood-2012-08-449819","article-title":"VCAM-1 and VAP-1 recruit myeloid cells that promote pulmonary metastasis in mice","volume":"121","author":"Ferjan\u010di\u010d","year":"2013","journal-title":"Blood"},{"key":"10.1016\/j.ejpb.2021.05.014_b0110","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1038\/nri2156","article-title":"Getting to the site of inflammation: The leukocyte adhesion cascade updated","volume":"7","author":"Ley","year":"2007","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.ejpb.2021.05.014_b0115","doi-asserted-by":"crossref","first-page":"1208086","DOI":"10.1155\/2019\/1208086","article-title":"How adhesion molecule patterns change while neutrophils traffic through the lung during inflammation","volume":"2019","author":"Konrad","year":"2019","journal-title":"Mediators Inflammation"},{"key":"10.1016\/j.ejpb.2021.05.014_b0120","doi-asserted-by":"crossref","first-page":"2219","DOI":"10.1021\/acs.nanolett.9b03883","article-title":"Self-delivery micellar nanoparticles prevent premetastatic niche formation by interfering with the early recruitment and vascular destruction of granulocytic myeloid-derived suppressor cells","volume":"20","author":"Long","year":"2020","journal-title":"Nano Lett."},{"key":"10.1016\/j.ejpb.2021.05.014_b0125","doi-asserted-by":"crossref","first-page":"1476","DOI":"10.1002\/jbm.a.35286","article-title":"Transferrin surface-modified PLGA nanoparticles-mediated delivery of a proteasome inhibitor to human pancreatic cancer cells","volume":"103","author":"Frasco","year":"2015","journal-title":"J. Biomed. Mater. Res. Part A"},{"key":"10.1016\/j.ejpb.2021.05.014_b0130","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1038\/cgt.2013.9","article-title":"Transferrin receptor targeting nanomedicine delivering wild-type p53 gene sensitizes pancreatic cancer to gemcitabine therapy","volume":"20","author":"Camp","year":"2013","journal-title":"Cancer Gene Ther."},{"key":"10.1016\/j.ejpb.2021.05.014_b0135","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1021\/acs.biomac.5b01419","article-title":"EGFR-targeted polymeric mixed micelles carrying gemcitabine for treating pancreatic cancer","volume":"17","author":"Mondal","year":"2016","journal-title":"Biomacromolecules"},{"key":"10.1016\/j.ejpb.2021.05.014_b0140","doi-asserted-by":"crossref","first-page":"206","DOI":"10.4161\/cbt.13.4.18692","article-title":"RGD-conjugated albumin nanoparticles as a novel delivery vehicle in pancreatic cancer therapy","volume":"13","author":"Ji","year":"2012","journal-title":"Cancer Biol. Ther."},{"key":"10.1016\/j.ejpb.2021.05.014_b0145","doi-asserted-by":"crossref","first-page":"1689","DOI":"10.7150\/thno.18125","article-title":"Tumor penetrating theranostic nanoparticles for enhancement of targeted and image-guided drug delivery into peritoneal tumors following intraperitoneal delivery","volume":"7","author":"Gao","year":"2017","journal-title":"Theranostics"},{"key":"10.1016\/j.ejpb.2021.05.014_b0150","doi-asserted-by":"crossref","first-page":"1800229","DOI":"10.1002\/advs.201800229","article-title":"Enhanced melanoma-targeted therapy by \u201cFru-blocked\u201d phenyboronic acid-modified multiphase antimetastatic micellar nanoparticles","volume":"5","author":"Long","year":"2018","journal-title":"Adv. Sci."},{"key":"10.1016\/j.ejpb.2021.05.014_b0155","doi-asserted-by":"crossref","first-page":"12022","DOI":"10.1021\/ja902964m","article-title":"Noninvasive sialic acid detection at cell membrane by using phenylboronic acid modified self-assembled monolayer gold electrode","volume":"131","author":"Matsumoto","year":"2009","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.ejpb.2021.05.014_b0160","doi-asserted-by":"crossref","first-page":"3199","DOI":"10.1158\/0008-5472.CAN-14-0728","article-title":"Sialic acids sweeten a tumor's life","volume":"74","author":"B\u00fcll","year":"2014","journal-title":"Cancer Res."},{"key":"10.1016\/j.ejpb.2021.05.014_b0165","doi-asserted-by":"crossref","first-page":"386","DOI":"10.3389\/fcimb.2018.00386","article-title":"H5N1 influenza a virus replicates productively in pancreatic cells and induces apoptosis and pro-Inflammatory cytokine response","volume":"8","author":"Huo","year":"2018","journal-title":"Front. Cell. Infect. Microbiol."},{"key":"10.1016\/j.ejpb.2021.05.014_b0170","doi-asserted-by":"crossref","unstructured":"S. Bassaga\u00f1as, M. P\u00e9rez-Garay, R. Peracaula, Cell surface sialic acid modulates extracellular matrix adhesion and migration in pancreatic adenocarcinoma cells, Pancreas (Philadelphia, PA, U. S.) 43 (2014) 109-117. doi: 10.1097\/MPA.0b013e31829d9090.","DOI":"10.1097\/MPA.0b013e31829d9090"},{"key":"10.1016\/j.ejpb.2021.05.014_b0175","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1158\/2326-6066.CIR-16-0297","article-title":"Myeloid-derived suppressor cells","volume":"5","author":"Gabrilovich","year":"2017","journal-title":"Cancer Immunol. Res."},{"key":"10.1016\/j.ejpb.2021.05.014_b0180","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1016\/j.it.2016.01.004","article-title":"The nature of myeloid-derived suppressor cells in the tumor microenvironment","volume":"37","author":"Kumar","year":"2016","journal-title":"Trends Immunol."},{"key":"10.1016\/j.ejpb.2021.05.014_b0185","doi-asserted-by":"crossref","unstructured":"B. L. Mundy-Bosse, G. B. Lesinski, A. C. Jaime-Ramirez, K. Benninger, M. Khan, P. Kuppusamy, K. Guenterberg, S. V. Kondadasula, A. R. Chaudhury, K. M. La Perle, M. Kreiner, G. Young, D. C. Guttridge, W. E. 3rd. Carson, Myeloid-derived suppressor cell inhibition of the IFN response in tumor-bearing mice, Cancer Res. 71 (2011) 5101-5110. doi: 10.1158\/0008-5472.CAN-10-2670.","DOI":"10.1158\/0008-5472.CAN-10-2670"},{"key":"10.1016\/j.ejpb.2021.05.014_b0190","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1186\/s12964-015-0093-y","article-title":"Immune checkpoint regulator PD-L1 expression on tumor cells by contacting CD11b positive bone marrow derived stromal cells","volume":"13","author":"Noh","year":"2015","journal-title":"Cell Commun. Signal."},{"key":"10.1016\/j.ejpb.2021.05.014_b0195","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1136\/gutjnl-2016-312078","article-title":"Myeloid cells are required for PD-1\/PD-L1 checkpoint activation and the establishment of an immunosuppressive environment in pancreatic cancer","volume":"66","author":"Zhang","year":"2017","journal-title":"Gut"},{"key":"10.1016\/j.ejpb.2021.05.014_b0200","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1007\/s11060-015-1826-x","article-title":"Heparin in malignant glioma: Review of preclinical studies and clinical results","volume":"124","author":"Schnoor","year":"2015","journal-title":"J. Neuro-Oncol."},{"key":"10.1016\/j.ejpb.2021.05.014_b0205","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1016\/j.biopha.2011.04.007","article-title":"Enhanced anti-angiogenesis and anti-tumor activity of endostatin by chemical modification with polyethylene glycol and low molecular weight heparin","volume":"66","author":"Tan","year":"2012","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.ejpb.2021.05.014_b0210","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1111\/j.1600-0463.2006.apm_235.x","article-title":"Low-molecular-weight heparins and angiogenesis","volume":"114","author":"Norrby","year":"2006","journal-title":"APMIS"}],"container-title":["European Journal of Pharmaceutics and Biopharmaceutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0939641121001442?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0939641121001442?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,15]],"date-time":"2025-10-15T16:45:59Z","timestamp":1760546759000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0939641121001442"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,8]]},"references-count":42,"alternative-id":["S0939641121001442"],"URL":"https:\/\/doi.org\/10.1016\/j.ejpb.2021.05.014","relation":{},"ISSN":["0939-6411"],"issn-type":[{"value":"0939-6411","type":"print"}],"subject":[],"published":{"date-parts":[[2021,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Phenylboronic acid modified nanoparticles simultaneously target pancreatic cancer and its metastasis and alleviate immunosuppression","name":"articletitle","label":"Article Title"},{"value":"European Journal of Pharmaceutics and Biopharmaceutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejpb.2021.05.014","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}